Company: TVRD
Filing Date: 2025-05-30
Form Type: S-1
Source: 0001104659-25-054853
Chunk: 364

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-05-30
Form: S-1
Chunk 364
---
 | 1,504,141 | ​ |   | 1,490,377 |
| Other comprehensive income (loss), net of tax of $0:                                       | ​ |                         |           | ​ |   |           | ​ |   |           |
| Change in unrealized gains (losses) on available-for-sale marketable securities            | ​ |                         |       260 | ​ |   |     1,412 | ​ |   |    -1,314 |
| Total comprehensive loss                                                                   | ​ | $                       |   -70,607 | ​ | $ |  -117,101 | ​ | $ |   -86,788 |

See Notes to Consolidated Financial Statements.

F-53

CARA THERAPEUTICS, INC. CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (amounts in thousands, except share and per share data)

| ​                                                                         
 ​                                                                         
 ​                                                                         
 ​                                                                         
 ​                                                                         | ​ 
 ​ 
 ​ 
 ​ |            ​ 
            ​ 
            ​ 
 Common Stock 
       Shares | ​ 
 ​ 
 ​ | ​      
 ​      
 ​      
 Amount | ​ 
 ​ 
 ​ | ​ 
 ​ 
 ​ 
 ​ | ​          
 ​          
 Additional 
 Paid-In    
 Capital    |       ​ 
       ​ | ​ 
 ​ 
 ​ 
 ​ | ​           
 ​           
 ​           
 Accumulated 
 Deficit     |        ​ 
        ​ 
        ​ | ​ 
 ​ 
 ​ 
 ​ | ​             
 Accumulated   
 Other         
 Comprehensive 
 Income (Loss) |      ​ | ​ 
 ​ 
 ​ 
 ​ | ​             
 ​             
 Total         
 Stockholders’ 
 Equity        |        ​ 
        ​ |
|:--------------------------------------------------------------------------|:--|-------------:|:--|:-------|--:|:--|:-----------|--------:|:--|:------------|---------:|:--|:--------------|-------:|:--|:--------------|---------:|
| Balance at December 31, 2021                                              | ​ |    1,485,578 | ​ | $      | 1 | ​ | $          | 708,637 | ​ | $           | -480,758 | ​ | $             |   -358 | ​ | $             |  227,522 |
| Stock-based compensation expense                                          | ​ |            — | ​ | ​      | — | ​ | ​          |  14,345 | ​ | ​